Use of ADAM 12 for diagnosis and therapy of preeclampsia
Preeclampsia is a disorder affecting
about 5% of pregnant women. It becomes manifest in the last trimester of pregnancy and is characterized by high blood pressure, protein in the urine, and, sometimes, edema of the face and hands. When left untreated, preeclampsia can lead to severe problems, endangering both mother and fetus. High blood pressure constricts the blood vessels in the uterus that supply the fetus with oxygen and nutrients. Fetal growth is retarded. Preeclampsia can increase the risk of: placental abruption kidney failure cerebral hemorrhage intravascular coagulation lung edema circulatory collapse
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
